cannabis indica

Índice completo — página 67 de 77

Estudos 6.601 a 6.700 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2009. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.601 a 6.700

  1. 2009

    Cannabidiol Ameliorates Cognitive And Motor Impairments In Mice With Bile Duct Ligation

    FavorávelEstudo em AnimaisCâncerDisfunção CognitivaFibrose+3
  2. 2009

    Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice.

    FavorávelEstudo em AnimaisDiabetes
  3. 2009

    Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death.

    FavorávelEstudo em AnimaisNefropatia Induzida por Medicamentos
  4. 2009

    Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats.

    FavorávelEstudo em AnimaisDoença PeriodontalDor — Dentária Aguda
  5. 2009

    Cannabidiol for the treatment of psychosis in Parkinson's disease

    FavorávelEnsaio ClínicoPsicoseDoença de Parkinson
  6. 2009

    Cannabidiol-2',6'-dimethyl Ether, A Cannabidiol Derivative, Is A Highly Potent And Selective 15-lipoxygenase Inhibitor

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Aterosclerose
  7. 2009

    Cannabidiol, A Nonpsychotropic Component Of Cannabis, Inhibits Cue-induced Heroin Seeking And Normalizes Discrete Mesolimbic Neuronal Disturbances

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Opioides
  8. 2009

    Cannabidiol: a promising drug for neurodegenerative disorders?

    FavorávelMetanáliseDoenças NeurodegenerativasDoença de Parkinson
  9. 2009

    Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.

  10. 2009

    Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model

  11. 2009

    Cannabinoid hyperemesis presenting to a New Zealand hospital

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  12. 2009

    Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognized manifestation of chronic cannabis abuse

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  13. 2009

    Cannabinoid Receptor 1 Is A Potential Drug Target For Treatment Of Translocation-positive Rhabdomyosarcoma

    FavorávelEstudo LaboratorialCâncerCâncer — Tecidos MolesCanabinoides Sintéticos HU-x
  14. 2009

    Cannabinoid Receptor Activation in the Basolateral Amygdala Blocks the Effects of Stress on the Conditioning and Extinction of Inhibitory Avoidance.

    FavorávelEstudo em AnimaisTEPTCanabinoides Sintéticos AM-xCanabinoides Sintéticos WIN-x
  15. 2009

    Cannabinoid system in the skin - a possible target for future therapies in dermatology

  16. 2009

    Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.

    FavorávelEnsaio Clínico Duplo-CegoDorEsclerose MúltiplaTetraidrocanabinol (THC)THC:CBD Farmacêutico
  17. 2009

    Cannabinoids and the skeleton: from marijuana to reversal of bone loss.

  18. 2009

    Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis

  19. 2009

    Cannabinoids for the treatment of dementia

    InconclusivoMetanálise ClínicaDoenças NeurodegenerativasDemência
  20. 2009

    Cannabinoids for Tourette's Syndrome.

    FavorávelMetanálise ClínicaTiques e Síndrome de Tourette
  21. 2009

    Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts.

    FavorávelEstudo LaboratorialEsclerose SistêmicaCanabinoides Sintéticos WIN-x
  22. 2009

    Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

  23. 2009

    Cannabis and anxiety: a critical review of the evidence

    InconclusivoMetanálise ClínicaAnsiedadeTetraidrocanabinol (THC)
  24. 2009

    Cannabis and caries--does regular cannabis use increase the risk of caries in cigarette smokers?

    DesfavorávelMetanáliseCáries
  25. 2009

    Cannabis and psychosis: search of a causal link through a critical and systematic review

    DesfavorávelMetanálise ClínicaPsicoseTetraidrocanabinol (THC)
  26. 2009

    Cannabis and Suicide: Longitudinal Study

    InconclusivoMetanáliseTentativa de Suicídio
  27. 2009

    Cannabis As A Substitute For Alcohol And Other Drugs

    FavorávelMetanáliseDependência QuímicaDependência — Álcool
  28. 2009

    Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans

  29. 2009

    Cannabis Use and Destructive Periodontal Diseases Among Adolescents

    InconclusivoMetanáliseDoença Periodontal
  30. 2009

    CB(2) Cannabinoid Receptor Activation Is Cardioprotective in a Mouse Model of ischemia/reperfusion

  31. 2009

    CB1 cannabinoid receptor participates in the vascular hyporeactivity resulting from hemorrhagic shock in rats

  32. 2009

    CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents

  33. 2009

    CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis.

    FavorávelEstudo em AnimaisSepse
  34. 2009

    Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide

  35. 2009

    Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide/

    DesfavorávelEstudo LaboratorialInfecções FúngicasAnandamida (AEA)
  36. 2009

    Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous)

    DesfavorávelMetanálise ClínicaDorDor — Neuropatia PeriféricaDor — Polineuropatia Inflamatória
  37. 2009

    Chronic toxicology of cannabis

    DesfavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  38. 2009

    Cluster attacks responsive to recreational cannabis and dronabinol

    FavorávelMetanáliseEnxaquecaTHC Farmacêutico
  39. 2009

    Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão+1
  40. 2009

    Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial

    FavorávelEnsaio Clínico Duplo-CegoDPOC
  41. 2009

    Cyclical hyperemesis secondary to cannabis abuse

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  42. 2009

    Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisTetraidrocanabinol (THC)THC Farmacêutico+1
  43. 2009

    Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing

    InconclusivoEnsaio Clínico Duplo-CegoAnsiedadeTetraidrocanabinol (THC)
  44. 2009

    Drug reimbursement and GPs' prescribing decisions: a randomized case-vignette study about the pharmacotherapy of obesity associated with type 2 diabetes: how GPs react to drug reimbursement

    DesfavorávelEnsaio ClínicoObesidadeDiabetes
  45. 2009

    Effect of citral, eugenol, nerolidol and α-terpineol on the ultrastructural changes of Trichophyton mentagrophytes

    FavorávelEstudo LaboratorialInfecções Fúngicas
  46. 2009

    Effect of Phytoncide From Trees on Human Natural Killer Cell Function

    FavorávelEnsaio Clínico
  47. 2009

    Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial

    InconclusivoEnsaio Clínico Duplo-CegoDiabetesCanabinoide Sintético (não especificado)
  48. 2009

    Effect of Rowatinex on calculus clearance after extracorporeal shock wave lithotripsy

    FavorávelEnsaio Clínico Duplo-CegoCálculos Renais
  49. 2009

    Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans.

  50. 2009

    Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review.

    FavorávelMetanáliseAsmaTosseBronquite
  51. 2009

    Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting: A Systematic Literature Review.

  52. 2009

    Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders

    InconclusivoMetanáliseAnorexia (perda de apetite)Anorexia Nervosa
  53. 2009

    Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis.

  54. 2009

    Endocannabinoids in the Retina: From Marijuana to Neuroprotection

  55. 2009

    Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats

  56. 2009

    Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats

    FavorávelEstudo em AnimaisDorInflamaçãoDor — CrônicaAnandamida (AEA)Acupuntura (MTC)+1
  57. 2009

    Endogenous cannabinoids induce fever through the activation of CB1 receptors

    FavorávelEstudo em AnimaisAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+1
  58. 2009

    Impact of substance use on the physical health of patients with bipolar disorder

  59. 2009

    Increased Expressions Of Cannabinoid Receptor-1 And Transient Receptor Potential Vanilloid-1 In Human Prostate Carcinoma

    FavorávelEstudo LaboratorialCâncerCâncer — Próstata
  60. 2009

    Inhibition Of Fatty Acid Amide Hydrolase Reduces Reinstatement Of Nicotine Seeking But Not Break Point For Nicotine Self-administration--comparison With CB(1) Receptor Blockade

  61. 2009

    Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Opioides
  62. 2009

    Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis

    DesfavorávelEnsaio ClínicoEsclerose MúltiplaTHC:CBD Farmacêutico
  63. 2009

    Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa

  64. 2009

    Marijuana and chronic obstructive lung disease: a population-based study

    InconclusivoMetanáliseDPOCTosse
  65. 2009

    Marijuana Effectiveness As An HIV Self-care Strategy

    FavorávelMetanáliseAnsiedadeDepressãoNáusea e Vômito+1
  66. 2009

    Marijuana use in potential liver transplant candidates

    InconclusivoMetanáliseRejeição de Transplante
  67. 2009

    Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis

    InconclusivoEnsaio ClínicoDisfunção Cognitiva
  68. 2009

    Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção CognitivaTHC Farmacêutico
  69. 2009

    Nausea and vomiting in people with cancer and other chronic diseases

  70. 2009

    Neuroimaging in cannabis use: a systematic review of the literature

    FavorávelMetanálise ClínicaDisfunção CognitivaTetraidrocanabinol (THC)
  71. 2009

    Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

  72. 2009

    Opposite effects of anandamide and n‐arachidonoyl dopamine in the regulation of prostaglandin E2 and 8‐iso‐PGF2α formation in primary glial cells

    FavorávelEstudo LaboratorialInflamaçãoAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+1
  73. 2009

    Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines

  74. 2009

    Phytol-induced hepatotoxicity in mice

    DesfavorávelEstudo em AnimaisHepatiteHepatotoxicidade
  75. 2009

    Plant Derived Antioxidants - Geraniol and Camphene Protect Rat Alveolar Macrophages Against t-BHP Induced Oxidative Stress

    FavorávelEstudo LaboratorialEstresse OxidativoAsmaDPOC+1
  76. 2009

    Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.

  77. 2009

    Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans

    DesfavorávelEnsaio Clínico Duplo-CegoDisfunção CognitivaEsquizofreniaTetraidrocanabinol (THC)
  78. 2009

    Presence And Regulation Of Cannabinoid Receptors In Human Retinal Pigment Epithelial Cells

    FavorávelEstudo LaboratorialDegeneração MacularHidrolase de Amidas de Ácidos Graxos (FAAH)
  79. 2009

    Preventive and therapeutic anti-inflammatory properties of the sesquiterpene α-humulene in experimental airways allergic inflammation

    FavorávelEstudo LaboratorialAsma
  80. 2009

    Protective role of palmitoylethanolamide in contact allergic dermatitis.

    FavorávelEstudo em AnimaisDermatite de Contato AlérgicaOutros Compostos Relacionados
  81. 2009

    Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects

    FavorávelEnsaio Clínico Duplo-CegoEsquizofreniaTHC Farmacêutico
  82. 2009

    Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaTetraidrocanabinol (THC)THC:CBD Farmacêutico
  83. 2009

    R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway

    FavorávelEstudo LaboratorialCâncerCâncer — Colo do ÚteroOutros Compostos Relacionados
  84. 2009

    Recreational Drug Use And Risk Of Kaposi's Sarcoma In HIV- And HHV-8-coinfected Homosexual Men

    InconclusivoMetanáliseSarcoma de Kaposi
  85. 2009

    Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers

  86. 2009

    Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients

    DesfavorávelMetanáliseRejeição de TransplanteCanabinoides Sintéticos SR-x
  87. 2009

    Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway.

  88. 2009

    Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaHIV/AIDSTetraidrocanabinol (THC)
  89. 2009

    Stress Repression in Restrained Rats by (R)-(−)-Linalool Inhalation and Gene Expression Profiling of Their Whole Blood Cells

    FavorávelEstudo em AnimaisAnsiedade
  90. 2009

    Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain

    FavorávelEstudo em AnimaisLesões da Medula EspinhalCanabinoides Sintéticos WIN-x
  91. 2009

    Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception

  92. 2009

    Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer

  93. 2009

    Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia

    FavorávelEnsaio ClínicoEsquizofreniaTHC Farmacêutico
  94. 2009

    Systematic review and meta-analysis of cannabis treatment for chronic pain

    FavorávelMetanálise ClínicaDorDor — CrônicaTetraidrocanabinol (THC)
  95. 2009

    Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology

    DesfavorávelMetanálise ClínicaEfeitos Adversos da CannabisObesidadeHepatiteCanabinoides Sintéticos SR-x
  96. 2009

    The Activation Of Cannabinoid CB2 Receptors Stimulates In Situ And In Vitro Beta-amyloid Removal By Human Macrophages

    FavorávelEstudo LaboratorialDoença de AlzheimerDemênciaCanabinoides Sintéticos JWH-x
  97. 2009

    The CB(1)/CB(2) receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro

    FavorávelEstudo LaboratorialSarcoma de KaposiCanabinoides Sintéticos WIN-x
  98. 2009

    The dietary polyphenols trans-resveratrol and curcumin selectively bind human CB1 cannabinoid receptors with nanomolar affinities and function as antagonists/inverse agonists

    FavorávelEstudo em AnimaisObesidadeCúrcuma
  99. 2009

    The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial.

    FavorávelEnsaio Clínico Duplo-CegoInsônia e Distúrbios do SonoFibromialgia
  100. 2009

    The endocannabinoid system and the treatment of mood and anxiety disorders.

    FavorávelMetanáliseAnsiedadeDepressãoTEPT+1